The Federal Trade Commission on Tuesday announced that it has launched an inquiry in the ongoing U.S. baby-formula shortage. “The inquiry seeks information about the nature and prevalence of any deceptive, fraudulent, or otherwise unfair business practices aimed at taking advantage of families during this shortage,” the agency said in a statement. “It also aims to shed light on the factors that have led to concentration in the infant formula market and the fragility of the supply chains for these crucial products.”
This article was originally published by Marketwatch.com. Read the original article here.
